Literature DB >> 30603343

Design of and rationale for the Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System (J-DREAMS).

Takehiro Sugiyama1,2, Kengo Miyo3, Tetsuro Tsujimoto4, Ryota Kominami3,5, Hiroshi Ohtsu6, Mitsuru Ohsugi1,4, Kayo Waki7, Takashi Noguchi8,9, Kazuhiko Ohe9, Takashi Kadowaki10, Masato Kasuga11, Kohjiro Ueki4,12, Hiroshi Kajio4.   

Abstract

The "Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System" is a registry of patients with diabetes in Japan. The characteristics of this registry include a clinical information input process using the template function of an electronic medical record (EMR) system [the standard diabetes management template (SDMT)], a standardized exchangeable information storage format [the Standardized Structured Medical Information eXchange 2 (SS-MIX2)], and a secure and efficient information extraction process [Multipurpose Clinical Data Repository System (MCDRS)]. Together, these characteristics enable efficient data input during routine patient consultations, efficient and exact data extraction from each facility, and the integration of data across different facilities even though these data were generated by EMR systems from different vendors. The SDMT collects clinical information including the type of diabetes, body height and weight, blood pressure, lifestyle, and comorbidities. Completing this template triggers the automatic collection of other information such as fundamental information (sex, year and month of birth, and facility), prescription information, and laboratory examination results. As the information from every routine consultation is saved with an anonymized patient ID, linked data can be used as panel data allowing longitudinal investigations. The data obtained from the registry will allow analyses, for exmaple, mortality and morbidity risk, by various characteristics or drug types and may reveal unmet needs that inform future diabetes care.

Entities:  

Keywords:  Diabetes; Electronic medical record; Japan; Medical informatics; Registry; SS-MIX2

Year:  2017        PMID: 30603343      PMCID: PMC6224921          DOI: 10.1007/s13340-017-0326-y

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  11 in total

1.  Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: a report from a collaborative initiative by six Japanese associations.

Authors:  Naoki Nakashima; Mitsuhiko Noda; Kohjiro Ueki; Tatsuhiko Koga; Michio Hayashi; Katsuya Yamazaki; Tomoko Nakagami; Makoto Ohara; Akira Gochi; Yasushi Matsumura; Michio Kimura; Kazuhiko Ohe; Dongchon Kang; Yoshiyuki Toya; Kunihiro Yamagata; Koutaro Yokote; Shunya Ikeda; Naohiro Mitsutake; Ryuichi Yamamoto; Yukio Tanizawa
Journal:  Diabetol Int       Date:  2019-04-25

2.  Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group.

Authors:  Itsuko Miyazawa; Hiroshi Maegawa; Aya Kadota; Takashi Nakamura; Makoto Konishi; Shinichi Ochi; Katsuyuki Miura; Motozumi Okamoto
Journal:  Diabetol Int       Date:  2022-02-17

Review 3.  The dawning of the digital era in the management of hypertension.

Authors:  Ryo Matsuoka; Hiroshi Akazawa; Satoshi Kodera; Issei Komuro
Journal:  Hypertens Res       Date:  2020-07-13       Impact factor: 3.872

Review 4.  Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.

Authors:  Katsutoshi Hiramatsu; Annabel Barrett; Yasuhiko Miyata
Journal:  Drugs Real World Outcomes       Date:  2021-06-19

5.  Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.

Authors:  Hajime Nagasu; Yuichiro Yano; Hiroshi Kanegae; Hiddo J L Heerspink; Masaomi Nangaku; Yosuke Hirakawa; Yuka Sugawara; Naoki Nakagawa; Yuji Tani; Jun Wada; Hitoshi Sugiyama; Kazuhiko Tsuruya; Toshiaki Nakano; Shoichi Maruyama; Takashi Wada; Kunihiro Yamagata; Ichiei Narita; Kouichi Tamura; Motoko Yanagita; Yoshio Terada; Takashi Shigematsu; Tadashi Sofue; Takafumi Ito; Hirokazu Okada; Naoki Nakashima; Hiromi Kataoka; Kazuhiko Ohe; Mihoko Okada; Seiji Itano; Akira Nishiyama; Eiichiro Kanda; Kohjiro Ueki; Naoki Kashihara
Journal:  Diabetes Care       Date:  2021-09-30       Impact factor: 19.112

6.  Improvement of the Japanese healthcare data system for the effective management of patients with COVID-19: A national survey.

Authors:  Kohei Takeshita; Hiroyuki Takao; Seiya Imoto; Yuichi Murayama
Journal:  Int J Med Inform       Date:  2022-03-24       Impact factor: 4.730

7.  Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.

Authors:  Aiko Terakawa; Ryotaro Bouchi; Noriko Kodani; Tomoko Hisatake; Takehiro Sugiyama; Michihiro Matsumoto; Noriko Ihana-Sugiyama; Mitsuru Ohsugi; Kohjiro Ueki; Hiroshi Kajio
Journal:  J Diabetes Investig       Date:  2022-02-16       Impact factor: 3.681

8.  Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake.

Authors:  Hirotaka Watanabe; Mitsuyoshi Takahara; Naoto Katakami; Taka-Aki Matsuoka; Iichiro Shimomura
Journal:  Diabetol Int       Date:  2020-05-26

9.  Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).

Authors:  Tadashi Sofue; Naoki Nakagawa; Eiichiro Kanda; Hajime Nagasu; Kunihiro Matsushita; Masaomi Nangaku; Shoichi Maruyama; Takashi Wada; Yoshio Terada; Kunihiro Yamagata; Ichiei Narita; Motoko Yanagita; Hitoshi Sugiyama; Takashi Shigematsu; Takafumi Ito; Kouichi Tamura; Yoshitaka Isaka; Hirokazu Okada; Kazuhiko Tsuruya; Hitoshi Yokoyama; Naoki Nakashima; Hiromi Kataoka; Kazuhiko Ohe; Mihoko Okada; Naoki Kashihara
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

10.  Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan.

Authors:  Ryotaro Bouchi; Takehiro Sugiyama; Atsushi Goto; Kenjiro Imai; Noriko Ihana-Sugiyama; Mitsuru Ohsugi; Toshimasa Yamauchi; Takashi Kadowaki; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2021-08-17       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.